Dsp7A26K25
3-[5-(cyclopropylmethyl)-1,3,4-oxadiazol-2-yl]-5-(1-piperidin-4-ylpyrazol-4-yl)pyridin-2-amine
Molecular Identity
Dsp7A26K25
3-[5-(cyclopropylmethyl)-1,3,4-oxadiazol-2-yl]-5-(1-piperidin-4-ylpyrazol-4-yl)pyridin-2-amine
PubChem CID: 118110201
2D Structure
Properties
C19H23N7O
Molecular Formula
365.40
Molecular Weight
g/mol
365.1964
Exact Mass
Da
1.4
XLogP
Drug-like (Lipinski: < 5)
108
TPSA
Good oral absorption (< 140 A²)
2
H-Bond Donors
7
H-Bond Acceptors
498
Complexity
SMILES
Canonical SMILES
SMILES: C1CC1CC2=NN=C(O2)C3=C(N=CC(=C3)C4=CN(N=C4)C5CCNCC5)NIsomeric SMILES
SMILES: C1CC1CC2=NN=C(O2)C3=C(N=CC(=C3)C4=CN(N=C4)C5CCNCC5)NSynonyms(20)
SLC-391SLC391SLC0211SLC-0211DSP7A26K25UNII-DSP7A26K251783825-18-2SLC-391 [WHO-DD]2-Pyridinamine, 3-(5-(cyclopropylmethyl)-1,3,4-oxadiazol-2-yl)-5-(1-(4-piperidinyl)-1H-pyrazol-4-yl)-3-(5-(Cyclopropylmethyl)-1,3,4-oxadiazol-2-yl)-5-(1-(4-piperidinyl)-1H-pyrazol-4-yl)-2-pyridinamine2-Pyridinamine, 3-[5-(cyclopropylmethyl)-1,3,4-oxadiazol-2-yl]-5-[1-(4-piperidinyl)-1H-pyrazol-4-yl]-3-[5-(Cyclopropylmethyl)-1,3,4-oxadiazol-2-yl]-5-[1-(4-piperidinyl)-1H-pyrazol-4-yl]-2-pyridinamineSlc 391orb3136397CHEMBL5095196
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Dsp7A26K25
Loading drug network...